Postprogression outcomes in patients with ovarian carcinoma associated with amutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3 Meeting Abstract
Industry Collaboration
International Collaboration